Farnesyltransferase Inhibitors [MoA] - N0000193939

Pharmacologic Class Information

Pharmacologic Code N0000193939
Pharmacologic Name Farnesyltransferase Inhibitors
Pharmacologic Uses
  • farnesyltransferase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Farnesyltransferase Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Farnesyltransferase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
73079-050Zokinvy Non-Proprietary Name: LonafarnibCapsuleOralEiger Biopharmaceuticals, Inc.ACTIVE
73079-075Zokinvy Non-Proprietary Name: LonafarnibCapsuleOralEiger Biopharmaceuticals, Inc.ACTIVE